Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-22-003428
Filing Date
2022-02-25
Accepted
2022-02-25 16:36:18
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 3780
  Complete submission text file 0001225208-22-003428.txt   5080
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HONEYWELL 300 S. TRYON STREET CHARLOTTE NC 28202
Business Address
Adamczyk Darius (Reporting) CIK: 0001605056 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03215 | Film No.: 22680826